-
News | 2013.10.09
Fine-tuning the approach to malaria and toxoplasmosis research
A study carried out by teams from the Institut Pasteur, the Institut Cochin (Inserm, CNRS, Paris Descartes University), and the Wellcome Trust Centre for Molecular Parasitology at the University of Glasgow, may very well redefine current approaches to malaria and toxoplasmosis research in terms of treatment development. Their research which focuses on the role played by the protein AMA1 (present...
-
News | 2013.09.30
Potential therapeutic targets for blocking AIDS virus replication
Scientists from the Institut Pasteur and Inserm have identified several proteins in humans as potential new therapeutic targets for treating the AIDS virus. These proteins are part of a complex cellular mechanism that blocks the virus replication in cells called macrophages. The discovery of this mechanism and the proteins involved gives scientists a solid theoretical basis for developing new...
-
News | 2013.08.01
Dengue: identifying mosquito genetic factors that control virus transmission
Dengue is currently the most common insect-borne viral disease of humans worldwide. Scientists from the Institut Pasteur, the French National Center for Scientific Research (CNRS), and the Armed Forces Research Institute of Medical Sciences (AFRIMS) have discovered several genetic factors controlling the transmission of various dengue virus strains in a natural population of mosquitoes in...
-
News | 2013.05.28
Worldwide Outbreak of Highly Antibiotic-Resistant Salmonella Risks Spreading to European Poultry Farms
In a study published online May 28th for the Lancet Infectious Diseases medical journal, scientists at the Institut Pasteur in Paris and the Institut Pasteur in Morocco once again bring attention to the rapid worldwide spread of Salmonella Kentucky (S. Kentucky), a bacterium showing resistance to several classes of antibiotics. S. Kentucky is responsible for foodborne infections and has spread at...
-
News | 2013.11.27
Clinical trial launched to treat Sanfilippo B syndrome using gene therapy
A phase I/II gene therapy clinical trial for children suffering from Sanfilippo B syndrome, a rare genetic disease, enrolled a first patient in October of this year. The trial is being carried out and coordinated by the Institut Pasteur (the trial’s sponsor), Inserm, AFM-Téléthon and Vaincre les Maladies Lysosomales (VML). It is being conducted at Bicêtre Hospital (AP-HP) in Paris. If the...
-
News | 2014.01.16
A new bacterial mechanism for evading the immune system
A team of scientists from the Institut Pasteur, the CNRS and Paris Diderot University has identified a new regulation mechanism that enables a pathogenic bacterium of the Streptococcus genus to rapidly adapt to its host. This study was published on January 16, 2014 in PLoS Pathogens. The mechanism in question enables the bacterium to minimize its exposure to the immune system while maintaining...
-
News | 2014.03.10
Inauguration of a Regional Platform of Research on transmissible and emerging infectious diseases in Southeast Asia (PRR-Asia)
Southeast Asia (SEA) is affected by emerging infectious diseases, and emerging outbreaks challenge the medical and scientific communities. The emergence of new diseases or their resistance to anti-microbial drugs in SEA is a complex mechanism which requires more interest on the diseases, on the condition of their emergence and on the diffusion of the causative agents. The study of infection...
-
News | 2014.04.01
Join us for the live webcast of the event Uniting to Combat Neglected Tropical Diseases: A Conversation on Progress
Two years ago, the global community convened in London to hold the most significant international meeting on NTDs in history. The event galvanized major commitments from a diverse set of partners to eliminate or control 10 NTDs by 2020 – these commitments are now known as the London Declaration. On 2 April, this unique group of partners will come together once more to discuss...
-
News | 2014.03.05
A renovation for the Institut Pasteur in Madagascar
On March 6th, 2014 the Professor Christian BRECHOT, President of the Institut Pasteur, has inaugurated the Girard renovated building of the Institut Pasteur in Madagascar. This building built in 1935 has been brought up to international standards with fundings from the French Ministry of Research to meet quality and scientific excellence requirement. The Girard building hosts the following units...
-
News | 2014.02.18
The Institut Pasteur in Guadeloupe is mobilizing against Chikungunya
The Institut Pasteur in Guadeloupe is mobilizing against Chikungunya through the development of a rapid detection test allowing the Medical Laboratory to bring a diagnosis to patients within five days after blood sample. Involved from the beginning of Chikungunya's epidemic, the Institut Pasteur in French Guiana, with six International Reference Laboratories in Americas Region, showed the...
